Dendritic cells therapy confers a protective microenvironment in murine pregnancy

Scandinavian Journal of Immunology

Volumn 64, Issue 5, 2006, Pages 493-499

  Miranda, S ^b   Litwin, S ^b   Barrientos, G ^b,c   Szereday, L ^d   Chuluyan, E ^e   Bartho, J S ^d   Arck, P C ^c   Blois, S M ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF PÉCS   (Hungary)

^e HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING AGENT; CD8 ANTIGEN; PROGESTERONE INDUCED BLOCKING FACTOR; PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ABORTION; ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FETOPLACENTAL UNIT; IMMUNOREGULATION; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ABORTION, HABITUAL; ABORTION, INDUCED; ABORTION, SPONTANEOUS; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD8; CULTURE MEDIA, CONDITIONED; DENDRITIC CELLS; FEMALE; MALE; MICE; MICE, INBRED DBA; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY, ANIMAL; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; UTERUS;

EID: 33749616640     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01841.x     Document Type: Article

References (54)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
2. Menges M, Rossner S, Voigtlander C et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002;195:15-21.
3. Darmochwal-Kolarz D, Rolinski J, Tabarkiewicz J et al. Blood myeloid and lymphoid dendritic cells are stable during the menstrual cycle but deficient during mid-gestation. J Reprod Immunol 2003;59:193-203.
4. Askelund K, Liddell HS, Zanderigo AM et al. CD83(+)dendritic cells in the decidua of women with recurrent miscarriage and normal pregnancy. Placenta 2004;25:140-5.
5. Blois S, Alba Soto CD, Olmos S et al. Therapy with dendritic cells influences the spontaneous resorption rate in the CBA/J x DBA/2J mouse model. Am J Reprod Immunol 2004;51:40-48.
6. Finkelman FD, Lees A, Birnbaum R, Gause WC, Morris SC. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 1996;157:1406-14.
7. Gabrilovich DI, Cunningham HT, Carbone DP. IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer. J Immunother Emphasis Tumor Immunol 1996;6:414-8.
8. Toes RE, van der Voort EI, Schoenberger SP et al. Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J Immunol 1998;160:4449-56.
9. Morel PA, Feili-Hariri M, Coates PT, Thomson AW. Dendritic cells, T cell tolerance and therapy of adverse immune reactions. Clinical & Experimental Immunology 2003;133:1-10.
10. Zitvogel L, Mayordomo JI, Tjandrawan T et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 1996;183:87-97.
11. Lutz MB, Suri RM, Niimi M et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000;7:1813-22.
12. Lutz MB, Kukutsch NA, Menges M, Rossner S, Schuler G. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur J Immunol 2000;4:1048-52.
13. Hunt JS, Petroff MG, Burnett TG. Uterine leukocytes: key players in pregnancy. Semin Cell Dev Biol 2000;2:127-37.
14. Joachim R, Zenclussen AC, Polgar B et al. The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response. Steroids 2003;10-13:931-40.
15. Szekeres-Bartho J, Faust Z, Varga P, Szereday L, Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 1996;4:348-51.
16. Mellor AL, Munn DH. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol 2000;18:367-91.
17. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2005;3:266-71.
18. Blois S, Tometten M, Kandil J et al. Intercellular adhesion molecule-1/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the fetomaternal interface in murine pregnancies. J Immunol 2005;174:1820-9.
19. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000;287:498-501.
20. Clark DA, Coulam CB, Daya S, Chaouat G. Unexplained sporadic and recurrent miscarriage in the new millennium: a critical analysis of immune mechanisms and treatments. Hum Reprod Update 2001;5:501-11.
21. Kalinski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML. Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses. Adv Exp Med Biol 1997;417:363-7.
22. Zal T, Volkmann A, Stockinger B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J Exp Med 1994;180:2089-99.
23. Shaw J, Grund V, Durling L, Crane D, Caldwell HD. Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective. Infect Immun 2002;70:1097-105.
24. Inaba K, Turley S, Yamaide F et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998;188:2163-73.
25. + regulatory T cells by human placental trophoblasts. J Immunol 2005;174:7539-47.
26. Tilburgs T, Roelen DL, van der Mast BJ et al. Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy. Placenta 2006;27:47-53.
27. Szekeres-Bartho J, Autran B, Debre P, Andreu G, Denver L, Chaouat G. Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 1989;122:281-94.
28. + cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile. J Immunol 2004;172:5893-9.
29. Mincheva-Nilsson L, Kling M, Hammarstrom S et al. Gamma delta T cells of human early pregnancy decidua: evidence for local proliferation, phenotypic heterogeneity, and extrathymic differentiation. J Immunol 1997;159:3266-77.
30. Arck PC, Ferrick DA, Steele-Norwood D et al. Murine T cell determination of pregnancy outcome. Cell Immunol 1999;196:71-79.
31. Polgar B, Barakonyi A, Xynos I, Szekeres-Bartho J. The role of gamma/delta T cell receptor positive cells in pregnancy. Am J Reprod Immunol 1999;41:239-44.
32. Szekeres-Bartho J, Barakonyi A, Par G, Polgar B, Palkovics T, Szereday L. Progesterone as an immunomodulatory molecule. Int Immunopharmacol 2001;6:1037-48.
33. Chen ZW. Comparative biology of gamma delta T cells. Sci Prog 2002;85:347-58.
34. Roussev RG, Higgins NG, McIntyre JA. Phenotypic characterization of normal human placental mononuclear cells. J Reprod Immunol 1993;25:15-29.
35. Szekeres-Bartho J, Barakonyi A, Polgar B et al. The role of g/d T cells in progesterone mediated immunomodulation during pregnancy: a review. Am J Reprod Immunol 1999;42:44-48.
36. Buonocore S, Flamand V, Goldman M, Braun MY. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft. Transplantation 2003;75:407-13.
37. Taner T, Hackstein H, Wang Z, Morelli AE, Thomson AW. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am J Transplant 2005;2:228-36.
38. Chaussabel D, Banchereau J. Dendritic cells, therapeutic vectors of immunity and tolerance. Am J Transplant 2005;2:205-6.
39. + T cell-dependent suppression of natural effector cell cytotoxicity against trophoblast target cells. Cell Immunol 1994;154:143-52.
40. Chang CC, Ciubotariu R, Manavalan JS et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002;3:237-43. Epub 2002 Jan 28.
41. Heyborne KD, Cranfill RL, Carding SR, Born WK, O'Brien RL. Characterization of gamma delta T lymphocytes at the maternal-fetal interface. J Immunol 1992;149:2872-8.
42. Meeusen E, Fox A, Brandon M, Lee CS. Activation of uterine intraepithelial gamma delta T cell receptor-positive lymphocytes during pregnancy. Eur J Immunol 1993;5:1112-7.
43. Meeusen EN, Bischof RJ, Lee CS. Comparative T-cell responses during pregnancy in large animals and humans. Am J Reprod Immunol 2001;46:169-79.
44. Hanninen A, Harrison LC. Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol Rev 2000;173:109-19.
45. Ingman WV, Robker RL, Woittiez K, Robertson SA. Null mutation in transforming growth factor beta1 disrupts ovarian function and causes oocyte incompetence and early embryo arrest. Endocrinology 2006;147:835-45.
46. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-62.
47. Huber S, Schramm C, Lehr HA et al. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 2004;173:6526-31.
48. Nagaeva O, Jonsson L, Mincheva-Nilsson L. Dominant IL-10 and TGF-beta mRNA expression in gammadeltaT cells of human early pregnancy decidua suggests immunoregulatory potential. Am J Reprod Immunol 2002;48:9-17.
49. Gorczynski RM, Chen Z, Zeng H, Fu XM. Specificity for in vivo graft prolongation in gamma delta T cell receptor+ hybridomas derived from mice given portal vein donor-specific preimmunization and skin allografts. J Immunol 1997;159:3698-706.
50. Szekeres-Bartho J, Hadnagy J, Pacsa AS. The suppressive effect of progesterone on lymphocyte cytotoxicity: unique progesterone sensitivity of pregnancy lymphocytes. J Reprod Immunol 1985;2:121-8.
51. Kelemen K, Bognar I, Paal M, Szekeres-Bartho J. A progesterone-induced protein increases the synthesis of asymmetric antibodies. Cell Immunol 1996;167:129-34.
52. Faust Z, Laskarin G, Rukavina D, Szekeres-Bartho J. Progesterone-induced blocking factor inhibits degranulation of natural killer cells. Am J Reprod Immunol 1999;42:71-75.
53. Szekeres-Bartho J, Faust Z, Varga P. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes. Am J Reprod Immunol 1995;34:342-8.
54. Laskarin G, Strbo N, Sotosek V et al. Progesterone directly and indirectly affects perforin expression in cytolytic cells. Am J Reprod Immunol 1999;42:312-20.